Applaud Medical is structured around development of new methods for treatment of Urinary (kidney) Stones - a medical problem that factors (in the United States alone) to <2,000,000 emergency room visits annually. Currently, treatment of large stones requires anesthesia in an operating room with a less invasive surgical intervention addressing the problem effectively - rendering them stone-free - in only some 50% of patients. The firm's Acoustic Enhancer is designed to accelerate and amplify the fragmentation process - providing faster procedures and better patient outcomes: an innovative kidney stone treatment that - for the first time - could allow urologists effectively to treat 5-15 millimeter stones with a simple outpatient procedure. In January 2022 it was announced that Applaud Medical had received the FDA Breakthrough Device Designation for the companyâs acoustic enhancer for use in conjunction with ureteroscopy wiith Laser Lithotripsy (URS-LL) for the fragmentation of calcium-based kidney stones Jan 31, 2022 |
